Target intelligence / Profile preview

RPL7L1 pseudogene 20 (RPL7L1P20)

Target: RPL7L1P20
Molecular classification: Other (Pseudogene)

Overview

RPL7L1 pseudogene 20 (abbreviated as RPL7L1P20) is designated as a pseudogene of the ribosomal protein L7-like 1 (RPL7L1) gene family. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they generally do not encode a functional protein and have no established role as therapeutic targets, biological functions, or direct associations with diseases. No evidence exists for RPL7L1P20 being biologically active, involved in disease processes, or interacting with drugs, and it is not considered a therapeutic target[7][8].

Other names: RPL7L1P20

Beyond the preview

Go deeper on RPL7L1 pseudogene 20 (RPL7L1P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPL7L1 pseudogene 20 (RPL7L1P20).

Explore the full profile